The Asian Fund for Cancer Research made this statement following the Friday, 26 July, announcement and dissemination of the Hong Kong Cancer Strategy: The Asian Fund for Cancer Research proudly supports and is committed to helping vigorously pursue the newly unveiled Hong Kong Cancer Strategy. We will fiercely fight to…...
Sarcoma Origin Identified
Cancer is anything but a straightforward disease; one tumor type can be entirely different from another not only in location, but causal agent and origin. There is differentiation even within the same type of cancer. Take sarcoma, which is in fact an umbrella term for nearly 100 cancers originating in the skeleton…...
Global Coalition for Adaptive Research’s Innovative Clinical Trial Platform Opens to Evaluate New Therapies for Brain Cancer
The Global Coalition for Adaptive Research (GCAR) announced today that the GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) clinical trial is opening its first clinical site, the Henry Ford Cancer Institute, and will begin enrolling patients this week. GBM AGILE is the world’s first global adaptive clinical trial platform…...
AFCR Scientific Advisory Board Chairman’s Brain Cancer Efforts Recognized
W.K. Alfred Yung, M.D., a brain cancer researcher and chairman of the Asian Fund for Cancer Research’s scientific advisory board, was last week presented with the 3rd Annual SNOChina Award for Outstanding Contributions of International Cooperation by the Chinese Medical Doctor Association’s (CMDA) Society for Neuro-Oncology (SNO). The presentation was…...
Yoga for Insomnia, Anxiety and Socializing in Cancer Patients
A discipline consisting of movements through a sequence of postures in coordination with focused breathing, yoga’s documented benefits include increased flexibility, better strength, lowered blood pressure and the reduced severity of insomnia. Many people attribute recovery from depression and anxiety to the regular practice of yoga. Could its practice be…...
Spurring on the Next Generation
The Asian Fund for Cancer Research and the US Chinese Anti-Cancer Association jointly awarded six outstanding Chinese cancer researchers in the early stages of their careers with the 2018 USCACA-AFCR Young Investigator Award. Scholars received a certificate for the Award and a cheque in the amount of U.S. $1,000 in…...
New Faces
The Asian Fund for Cancer Research is pleased and honored to have recently both expanded its board of directors and established a council of advisors. Franck Le Deu, a senior partner in the Hong Kong office of McKinsey & Company, where he leads the consultancy’s pharmaceuticals and medical products practice…...
The Pathfinder
The “Ras/Raf/MEK/ERK pathway” is a mouthful. Oncologists will tell you the same thing. But behind the long phrase is an important field of cancer research—one in which Jiancheng Hu, Ph.D., a scientist supported by the Asian Fund for Cancer Research since 2017, is a renowned expert. Ras is a family…...
Confronting Cancer Together—as One City
The Asian Fund for Cancer Research was proud to have been among the 50-plus organizations and companies to have participated in the Hong Kong Anti-Cancer Society’s Hong Kong Cancer Day activities, held Sunday, 9 December 2018. A full slate of family-friendly programming was presented to nearly 3,000 participants, including food,…...
